F Wong

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy
    Mical S Campbell
    Division of Gastroenterology, University of Pennsylvania Health Services, Philadelphia, PA 19104, USA
    Hepatology 42:635-40. 2005
  2. ncbi request reprint Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges?
    Florence Wong
    Hepatology 42:533-5. 2005
  3. ncbi request reprint The use of TIPS in chronic liver disease
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Ann Hepatol 5:5-15. 2006
  4. ncbi request reprint Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt
    George Therapondos
    Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada
    Eur J Gastroenterol Hepatol 18:1161-6. 2006
  5. pmc Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
    Francesco Salerno
    Department of Internal Medicine, Policlinico IRCCS San Donato, University of Milan, Via Morandi, 30, 20097 San Donato MI, Italy
    Gut 56:1310-8. 2007
  6. doi request reprint New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection
    Florence Wong
    Division of Gastroenterology, University of Toronto, Toronto, Ontario, Canada Electronic address
    Gastroenterology 145:1280-8.e1. 2013
  7. pmc Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Mitra K Nadim
    Department of Medicine, University of Southern California, 1520 San Pablo Street, Suite 4300, Los Angeles, CA 90033, USA
    Crit Care 16:R23. 2012
  8. doi request reprint Acute kidney injury in decompensated cirrhosis
    Cynthia D Tsien
    Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Gut 62:131-7. 2013
  9. doi request reprint Recent advances in our understanding of hepatorenal syndrome
    Florence Wong
    Toronto General Hospital, University of Toronto, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
    Nat Rev Gastroenterol Hepatol 9:382-91. 2012
  10. pmc Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club
    F Wong
    Division of Gastoenterology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Gut 54:718-25. 2005

Detail Information

Publications62

  1. ncbi request reprint Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy
    Mical S Campbell
    Division of Gastroenterology, University of Pennsylvania Health Services, Philadelphia, PA 19104, USA
    Hepatology 42:635-40. 2005
    ..Competing effects of hepatic encephalopathy, requirement for repeated LVP, and need for hospitalizations explain similar changes in quality of life between the two groups...
  2. ncbi request reprint Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges?
    Florence Wong
    Hepatology 42:533-5. 2005
  3. ncbi request reprint The use of TIPS in chronic liver disease
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Ann Hepatol 5:5-15. 2006
    ..All patients who require a TIPS for treatment of complications of cirrhosis should be referred for consideration of liver transplant...
  4. ncbi request reprint Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt
    George Therapondos
    Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada
    Eur J Gastroenterol Hepatol 18:1161-6. 2006
    ....
  5. pmc Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
    Francesco Salerno
    Department of Internal Medicine, Policlinico IRCCS San Donato, University of Milan, Via Morandi, 30, 20097 San Donato MI, Italy
    Gut 56:1310-8. 2007
  6. doi request reprint New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection
    Florence Wong
    Division of Gastroenterology, University of Toronto, Toronto, Ontario, Canada Electronic address
    Gastroenterology 145:1280-8.e1. 2013
    ..3 mg/dL in <48 hours. We performed a prospective study to evaluate the ability of these criteria to predict mortality within 30 days of hospitalization among patients with cirrhosis and infection...
  7. pmc Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Mitra K Nadim
    Department of Medicine, University of Southern California, 1520 San Pablo Street, Suite 4300, Los Angeles, CA 90033, USA
    Crit Care 16:R23. 2012
    ..Accordingly, we sought to review the available evidence, make recommendations and delineate key questions for future studies...
  8. doi request reprint Acute kidney injury in decompensated cirrhosis
    Cynthia D Tsien
    Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Gut 62:131-7. 2013
    ..It is unclear whether milder degrees of acute kidney injury (AKI), defined as a serum creatinine increase of over 26.4 μmol/l (0.3 mg/dl) or by 50% from baseline, also has a negative impact on patient outcomes...
  9. doi request reprint Recent advances in our understanding of hepatorenal syndrome
    Florence Wong
    Toronto General Hospital, University of Toronto, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
    Nat Rev Gastroenterol Hepatol 9:382-91. 2012
    ..In general, patients who have had >8-12 weeks of pretransplant dialysis should be considered for combined liver-kidney transplantation...
  10. pmc Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club
    F Wong
    Division of Gastoenterology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Gut 54:718-25. 2005
    ..The use of antibiotics has to be judicious, as their indiscriminate use can lead to antibiotic resistance with potentially disastrous consequences...
  11. doi request reprint Renal diseases and the liver
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, 9th Floor, North Wing, Room 983, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
    Clin Liver Dis 15:39-53. 2011
    ..If cirrhosis is present, renal transplant alone is contraindicated; combined liver and kidney transplantation is indicated in patients with end-stage renal disease and advanced cirrhosis...
  12. ncbi request reprint Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
    Florence Wong
    Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Hepatology 40:55-64. 2004
    ..In conclusion, TIPS is an effective treatment for type 1 HRS in suitable patients with cirrhosis and ascites, following the improvement of renal function with combination therapy of midodrine, octreotide, and albumin...
  13. ncbi request reprint The role of liver biopsy in the management of patients with liver disease
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, Canada
    Can J Gastroenterol 17:651-4. 2003
    ..Prognostic information can be obtained in patients with this disorder, as well as in those with alcoholic liver disease and viral hepatitis, and liver biopsy can be used as a guide to their management...
  14. ncbi request reprint Drug insight: the role of albumin in the management of chronic liver disease
    Florence Wong
    Department of Medicine, Toronto General Hospital, 9th Floor, North Wing, Room 983, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
    Nat Clin Pract Gastroenterol Hepatol 4:43-51. 2007
    ..Efforts should be made to define the indications for albumin use, dose of albumin required and predictors of response, so that patients gain the maximum benefit from its administration...
  15. ncbi request reprint Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome
    Florence Wong
    Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Canada
    Hepatology 47:160-8. 2008
    ..The plasma tezosentan concentrations were 79 +/- 34 ng/mL at a steady state during infusion at 0.3 mg/hour. The plasma endothelin-1 concentrations increased from 2.7 +/- 0.3 pg/mL at the baseline to 19.1 +/- 7.3 pg/mL (P < 0.05)...
  16. ncbi request reprint Hepatorenal syndrome: current management
    Florence Wong
    Toronto General Hospital, University of Toronto, Ninth Floor, North Wing, Room 983, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
    Curr Gastroenterol Rep 10:22-9. 2008
    ..Liver transplantation corrects many of the pathophysiological abnormalities associated with HRS, and is the best treatment option. Patient outcome is improved further if the renal function is normalized prior to liver transplantation...
  17. pmc Cirrhotic cardiomyopathy
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, 9th Floor, North Wing, Room 983, 200 Elizabeth Street, Toronto, ON, Canada, M5G 2C4
    Hepatol Int 3:294-304. 2009
    ..Long-term aldosterone antagonism may help reduce myocardial hypertrophy. Future studies should include further elucidation of pathogenetic mechanisms so as to develop effective treatment strategies...
  18. doi request reprint Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment
    Florence Wong
    Division of Gastroenterology, Department of Medicine, University of Toronto, 9N 983 Toronto General Hospital, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
    Gut 59:381-6. 2010
    ..Molecular adsorbent recirculating system (MARS) is a specialised form of dialysis that clears albumin-bound substances, including vasodilators, and therefore can potentially reduce systemic vasodilatation in cirrhosis...
  19. doi request reprint Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis
    Florence Wong
    Department of Medicine, University of Toronto, Canada
    J Hepatol 53:283-90. 2010
    ....
  20. doi request reprint Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario M5G2C4, Canada
    Gut 60:702-9. 2011
    ..Therefore, there is a need for a newer classification to include both functional and structural renal diseases...
  21. doi request reprint Management of ascites in cirrhosis
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    J Gastroenterol Hepatol 27:11-20. 2012
    ..Potential new treatment options for ascites include the use of various vasoconstrictors, vasopressin V(2) receptor antagonists, or the insertion of a peritoneo-vesical shunt, all of which could possibly improve the management of ascites...
  22. ncbi request reprint Liver and kidney diseases
    Florence Wong
    Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, 200 Elizabeth Street, Room 220, 9th Floor, Eaton Wing, M5G 2C4, ON, Canada
    Clin Liver Dis 6:981-1011. 2002
    ..The involvement of the liver and kidney in systemic conditions is common and adds to the morbidity and mortality of patients...
  23. ncbi request reprint A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial
    Florence Wong
    Department of Medicine, Toronto General Hospital, University of Toronto, Canada
    Hepatology 37:182-91. 2003
    ..Higher doses of VPA-985 may produce significant dehydration and will require close monitoring with their use...
  24. ncbi request reprint Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    F Wong
    Division of Gastroenterology, The Toronto General Hospital, University of Toronto, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
    Clin Sci (Lond) 101:621-8. 2001
    ..Levels of brain natriuretic peptide may prove to be useful as a marker for screening patients with cirrhosis for the presence of cirrhotic cardiomyopathy, and thereby identifying such patients for further investigations...
  25. pmc Sodium homeostasis with chronic sodium loading in preascitic cirrhosis
    F Wong
    Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, Toronto, Canada
    Gut 49:847-51. 2001
    ..Preascitic cirrhotic patients receiving 200 mmol of sodium daily for seven days remain in positive sodium balance. Thereafter, sodium handling is unknown...
  26. ncbi request reprint The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis
    Florence Wong
    Department of Medicine, Divisions of Gastroenterology and Cardiology, Toronto General Hospital, University of Toronto, Toronto, ON, Canada
    Hepatology 35:1449-58. 2002
    ....
  27. ncbi request reprint The pathophysiologic basis for the treatment of cirrhotic ascites
    F Wong
    Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Clin Liver Dis 5:819-32. 2001
    ..The ultimate challenge is to use the understanding of the pathophysiology to develop new strategies to prevent the development of ascites in cirrhosis...
  28. pmc The cardiac response to exercise in cirrhosis
    F Wong
    Division of Gastroenterology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Gut 49:268-75. 2001
    ..Impaired exercise capacity and oxygen consumption are common in cirrhosis...
  29. ncbi request reprint Review: the controversy over the pathophysiology of ascites formation in cirrhosis
    F Wong
    Department of Medicine, Toronto Hospital, University of Toronto, Ontario, Canada
    J Gastroenterol Hepatol 12:437-44. 1997
    ....
  30. ncbi request reprint Effects of insulin on renal function, sympathetic nervous activity and forearm blood flow in normal human subjects
    F Wong
    Department of Medicine, Toronto Hospital, Ont
    Clin Invest Med 20:344-53. 1997
    ..To assess fully the vasodilatory and sodium-retaining effects of insulin...
  31. ncbi request reprint Attributions of cause and recurrence in long-term breast cancer survivors
    D E Stewart
    University Health Network Women s Health Program, University of Toronto, Canada
    Psychooncology 10:179-83. 2001
    ..This survey sought to determine to what women survivors of breast cancer attributed the cause and lack of recurrence of their breast cancer, and whether these views were associated with specific health behaviors...
  32. pmc Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications
    G Sansoe
    Division of Gastroenterology, Department of Medicine, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4
    Gut 56:1117-23. 2007
    ..Preascitic cirrhosis is characterised by subtle renal sodium retention. Calcium inhibits Na(+)-K(+)-2Cl(-) cotransport in the Henle's loop and could potentially correct sodium-handling abnormalities at that site...
  33. ncbi request reprint Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites
    J P Allard
    Division of Gastroenterology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Am J Gastroenterol 96:2442-7. 2001
    ..CONCLUSION: In cirrhotic patients with refractory ascites, resolution of the ascites after TIPS placement resulted in improvement of several nutritional parameters, especially for body composition...
  34. pmc Portopulmonary hypertension in decompensated cirrhosis with refractory ascites
    F S Benjaminov
    Division of Gastroenterology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Gut 52:1355-62. 2003
    ..Its presence may preclude patients from receiving a transjugular intrahepatic portosystemic shunt or liver transplantation as a definitive treatment for their end stage cirrhosis...
  35. ncbi request reprint "What doesn't kill you makes you stronger": an ovarian cancer survivor survey
    D E Stewart
    University Health Network, University of Toronto, Toronto, Ontario, M5G 2N2, Canada
    Gynecol Oncol 83:537-42. 2001
    ..This survey was designed to learn more about the physical health and quality of life of ovarian cancer survivors without known active disease and not on treatment...
  36. ncbi request reprint New challenge of hepatorenal syndrome: prevention and treatment
    F Wong
    Division of Gastroenterology, Department of Medicine, The Toronto General Hospital, University of Toronto, Ontario, Canada
    Hepatology 34:1242-51. 2001
    ..The challenge now is to use all this information to improve our management of cirrhotic patients to prevent occurrence of HRS in the future...
  37. ncbi request reprint The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis
    George Therapondos
    Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Canada
    Hepatology 44:640-9. 2006
    ....
  38. ncbi request reprint Long-term breast cancer survivors: confidentiality, disclosure, effects on work and insurance
    D E Stewart
    University Health Network Women s Health Program, 657 Uniuversity Ave, University of Toronto, Toronto, Ontario, Canada M5G 2N2
    Psychooncology 10:259-63. 2001
    ..This study sought to determine the experience of Canadian breast cancer survivors with respect to the impact of cancer on confidentiality, work and insurance...
  39. doi request reprint The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt
    Rania Nancy Rabie
    The Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada
    Am J Gastroenterol 104:2458-66. 2009
    ..The aim of this study was to assess the utility of E/A ratio, an indicator of diastolic dysfunction, to predict ascites clearance and mortality after transjugular intrahepatic portosystemic stent shunt (TIPS) insertion...
  40. ncbi request reprint The views of ovarian cancer survivors on its cause, prevention, and recurrence
    D E Stewart
    University Health Network Women's Health Program, University of Toronto, Ontario, Canada
    Medscape Womens Health 6:5. 2001
    ..This may assist in framing the ongoing management of patients in personally meaningful ways, which may increase adherence to a healthy lifestyle, engender a sense of control, and improve quality of life...
  41. pmc Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin
    Morris Sherman
    Toronto General Hospital, University of Toronto, Toronto, Canada
    Can J Gastroenterol 20:479-85. 2006
    ....
  42. pmc Renal dysfunction in cirrhosis: diagnosis, treatment and prevention
    Elaine Yeung
    Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    MedGenMed 6:9. 2004
  43. doi request reprint Concentrations and chiral signatures of POPs in soils and sediments: a comparative urban versus rural study in Canada and UK
    F Wong
    Science and Technology Branch, Environment Canada, 4905 Dufferin St, Toronto, ON, Canada M3H 5T4
    Chemosphere 74:404-11. 2009
    ..However, no significant correlation was observed between EE% of any of the chiral chemicals and contaminant levels in the Toronto soils...
  44. ncbi request reprint Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety
    C S Ho
    Department of Medical Imaging, University of Toronto, University Health Network and Mt Sinai Hospital, Toronto, Canada
    Cardiovasc Intervent Radiol 30:241-7. 2007
    ..PEI with a multipronged needle is a new, safe, and efficacious method in treating medium-to-large-sized hepatocellular carcinoma under conscious sedation. Its survival benefits require further investigations...
  45. ncbi request reprint Radiation induced mucositis: co-ordinating a research agenda
    J R Wright
    Department of Radiation Oncology, Hamilton Regional Cancer Center, Cancer Care Ontario, Hamilton, Ontario, Canada
    Clin Oncol (R Coll Radiol) 15:473-7. 2003
    ..Any additional information needed before the launch of any potential trial was also requested. In this paper, we will review and summarise the outcomes from the radiation-induced mucositis sessions...
  46. ncbi request reprint Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis sc
    S El-Sayed
    Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
    J Clin Oncol 20:3956-63. 2002
    ....
  47. ncbi request reprint Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B
    S K Fung
    Department of Medicine, University of Toronto, Toronto, Ont, Canada
    J Viral Hepat 11:432-8. 2004
    ..Reinstitution of lamivudine resulted in prompt virological and biochemical responses. Our study demonstrates that a sustained response can be achieved after a 2-year course of lamivudine in a subset of patients with e-CHB...
  48. ncbi request reprint Cirrhotic cardiomyopathy: does it contribute to chronic fatigue and decreased health-related quality of life in cirrhosis?
    Nigel Girgrah
    Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada
    Can J Gastroenterol 17:545-51. 2003
    ..The presence of cirrhotic cardiomyopathy and the attendant poor cardiac response to physical stress may affect HRQoL and contribute to fatigue in these patients...
  49. doi request reprint Medical management of ascites
    Wesley Leung
    University of Toronto, Toronto General Hospital, Department of Medicine, Ontario, Canada
    Expert Opin Pharmacother 12:1269-83. 2011
    ..Ascites is a common complication of advanced cirrhosis that has a significant negative impact on survival. This review updates the reader on the medical management of ascites...
  50. ncbi request reprint The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome
    Laurie Blendis
    Sackler School of Medicine, University of Tel Aviv, Israel
    Clin Med 3:154-9. 2003
    ..However, recent non-controlled studies indicate exciting possibilities of medical therapy reversing HRS...
  51. ncbi request reprint Regarding the letter in response to our review: the management of cirrhotic ascites
    Elain Yeung
    MedGenMed 4:18; author reply 19. 2002
  52. ncbi request reprint Does losartan work after all?
    Laurence M Blendis
    Am J Gastroenterol 98:1222-4. 2003
  53. ncbi request reprint Hyponatremia in cirrhosis: Results of a patient population survey
    Paolo Angeli
    Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Hepatology 44:1535-42. 2006
    ..In conclusion, low serum sodium levels in cirrhosis are associated with severe ascites and high frequency of hepatic encephalopathy, spontaneous bacterial peritonitis, and hepatorenal syndrome...
  54. ncbi request reprint The North American Study for the Treatment of Refractory Ascites
    Arun J Sanyal
    Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia, USA
    Gastroenterology 124:634-41. 2003
    ..The clinical utility of transjugular intrahepatic portosystemic shunts (TIPS) vis-à-vis total paracentesis in the management of refractory ascites is unclear...
  55. doi request reprint Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial
    Pere Gines
    Hospital Clinic, University of Barcelona, Institut d Investigacions Biomédiques August Pi Sunyer IDIBAPS, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Barcelona, Catalunya, Spain
    Hepatology 48:204-13. 2008
    ..01 for all compared to placebo). Thirst was significantly more common in patients treated with satavaptan compared to those treated with placebo, whereas the frequency of other adverse events was similar among groups...
  56. ncbi request reprint Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data
    Francesco Salerno
    Department of Internal Medicine, IRCCS Policlinico San Donato, University of Milan, Milan, Italy
    Gastroenterology 133:825-34. 2007
    ..The aim of this study was to compare the effects of TIPS and large-volume paracentesis in cirrhotic patients with refractory ascites by means of meta-analysis of individual patient data from 4 randomized controlled trials...
  57. ncbi request reprint A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B
    Ching Lung Lai
    University of Hong Kong, China
    Gastroenterology 129:528-36. 2005
    ..A previous 4-week trial of telbivudine in patients with chronic hepatitis B indicated marked antiviral effects with good tolerability, leading to the present 1-year phase 2b trial...
  58. ncbi request reprint Portopulmonary hypertension: an increasingly important complication of cirrhosis
    Laurie Blendis
    Gastroenterology 125:622-4. 2003
  59. ncbi request reprint Sympathetic hyperactivity in pre-ascites
    Laurie Blendis
    Gastroenterology 122:1538-40; discussion 1540. 2002
  60. ncbi request reprint Excess nitric oxide in preascites: another piece in the puzzle
    Laurie Blendis
    Am J Gastroenterol 97:2167-9. 2002
  61. ncbi request reprint Prevention of varices rebleeding: are drugs better after all?
    Laurie Blendis
    Gastroenterology 122:832-3. 2002
  62. ncbi request reprint The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club
    Kevin P Moore
    Centre for Hepatology, Royal Free and University College Medical School, UCL, London, United Kingdom
    Hepatology 38:258-66. 2003
    ..Liver transplantation should be considered for all ascitic patients, and this should preferably be performed prior to the development of renal dysfunction to prevent further compromise of their prognosis...